Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in gastroenterology practice guidelines

American Journal of Gastroenterology

Volumn 108, Issue 11, 2013, Pages 1686-1693

  Feuerstein, Joseph D ^a   Gifford, Anne E ^a   Akbari, Mona ^a   Goldman, Jonathan ^a   Leffler, Daniel A ^a   Sheth, Sunil G ^a   Cheifetz, Adam S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONFLICT OF INTEREST; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENTERITIS; EVIDENCE BASED PRACTICE; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; INTERPERSONAL COMMUNICATION; MALPRACTICE; MEDICAL INFORMATION; MEDICAL SOCIETY; MEDICOLEGAL ASPECT; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SOCIETY;

CONFLICT OF INTEREST; DISCLOSURE; EVIDENCE-BASED MEDICINE; GASTROENTEROLOGY; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84887245560     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.150     Document Type: Article

References (51)

1. Institute of Medicine. Guidelines for Clinical Practice: From Development to Use. The National Academies Press, 1992.
2. Institute of Medicine (US). Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Graham R. Clinical Practice Guidelines We Can Trust. National Academies Press: Washington DC, 2011.
3. Lo B, Field MJ, Institute of Medicine (US). Committee on Confl ict of Interest in Medical Research Education and Practice\par. Confl ict of Interest in Medical Research, Education, and Practice. National Academies Press: Washington DC, 2009.
4. Brotman M, Allen JI, Bickston SJ et al. AGA Task Force on Quality in Practice: a national overview and implications for GI practice. Gastroenterology 2005; 129: 361-9. (Pubitemid 41002068)
5. The AGA Institute. Practice Recommendations Development Manual, Updated 2007 [cited 26 July 2012]; available from: http://www.gastro.org/practice/ medical-position-statements/Practice-Recommendations-Manual.pdf.
6. National Guideline Clearinghouse. Guideline Index, [cited 27 August 2012]; available from: http://guideline.gov/browse/index.aspx?alpha=A.
7. Lee DH, Vielemeyer O. Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med 2011; 171: 18-22.
8. Rowe IA, Parker R, Armstrong MJ et al. Assessment of the quality of evidence underlying international guidelines in liver disease. Am J Gastroenterol 2012; 107: 1276-82.
9. Tricoci P, Allen JM, Kramer JM et al. Scientifi c evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009; 301: 831-41.
10. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002; 287: 612-7. (Pubitemid 34252013)
11. J ø rgensen AW, Hilden J, G ø tzsche PC. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 2006; 333: 782.
12. Kesselheim AS, Robertson CT, Myers JA et al. A randomized study of how physicians interpret research funding disclosures. N Engl J Med 2012; 367: 1119-27.
13. American College of Gastroenterology. Clinical Guidelines (sortable list), [cited 26 July 2012]; available from: http://gi.org/clinical-guidelines/ clinical-guidelines-sortable-list/.
14. American Gastroenterological Association. Guidelines, [cited 26 July 2012]; available from: http://www.gastro.org/practice/medical- positionstatements.
15. American College of Gastroenterology. Guideline Development Policies. [cited 26 July 2012]; available from: http://gi.org/clinical-guidelines/ guideline-development-policies/.
16. AGA. Understanding the AGA Guideline Development Process, [cited 26 July 2012]; available from: http://www.gastro.org/mobiletools/news-item/1106.
17. American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers. Gastroenterology 1995; 108: 925-6.
18. AGA guideline archive [cited 26 July 2012]; available from: http://www. gastro.org/practice/medical-position-statements/archive.
19. American Gastroenterological Association. American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1702-4.
20. Chalasani N, Younossi Z, Lavine JE et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-609.
21. American Gastroenterological Association. American Gastroenterological Association medical position statement: parenteral nutrition. Gastroenterology 2001; 121: 966-9.
22. Kahrilas PJ, Shaheen NJ, Vaezi MF et al. American Gastroenterological Association medical position statement on the management of gastroesophageal refl ux disease. Gastroenterology 2008; 135: 1383-91, 1391 e1-5.
23. Farraye FA, Odze RD, Eaden J et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in infl ammatory bowel disease. Gastroenterology 2010; 138: 738-45.
24. Talley NJ, Vakil N, Practice Parameters Committee of the American College of G. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005; 100: 2324-37.
25. Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol 2012; 107: 345-60; quiz 361.
26. Sharma P, Kozarek R, Practice Parameters Committee of the American College of G. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 2010; 105: 258-73; quiz 274.
27. Ghany MG, Nelson DR, Strader DB et al. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54: 1433-44.
28. O ' Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Am J Gastroenterol 2010; 105: 14-32; quiz 33.
29. American Gastroenterological Association, Spechler SJ, Sharma P et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011; 140: 1084-91.
30. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95. (Pubitemid 351615355)
31. ASGE A, AGA. Statement Universal adoption of capnography for moderate sedation in adults undergoing upper endoscopy and colonoscopy has not been shown to improve patient safety or clinical outcomes and signifi-cantly increases costs for moderate sedation. 2012. [cited 26 July 2012]; available from: http://www.gastro.org/practice/resource-library/guidelines/Capnography-for- Moderate-Sedation.pdf.
32. AGA. Medical position statement on stem cell research and it's implications for treating GI cancers. 2008 [cited 26 July 2012]; available from: http://www.gastro.org/practice/medical-position-statements/stem-cellresearch- and-it-s-implications-for-treating-gi-cancers.
33. Kaltenbach T, Sano Y, Friedland S et al. American Gastroenterological Association (AGA) Institute technology assessment on image-enhanced endoscopy. Gastroenterology 2008; 134: 327-40. (Pubitemid 350309331)
34. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academies Press: Washington DC, USA, 2001.
35. Dienstag JL, McHutchison JG. American Gastroenterological Association medical position statement on the management of hepatitis C. Gastroenterology 2006; 130: 225-30. (Pubitemid 43049855)
36. American Gastroenterological Association. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology 2001; 121: 195-7.
37. Parkman HP, Hasler WL, Fisher RS et al. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 1589-91. (Pubitemid 39457782)
38. Mahadevan U, Kane S. American gastroenterological association institute medical position statement on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006; 131: 278-82. (Pubitemid 44015758)
39. American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 2003; 125: 1503-7.
40. Blei AT, Cordoba J, Practice Parameters Committee of the American College of G. Hepatic encephalopathy. Am J Gastroenterol 2001; 96: 1968-76.
41. Fekety R. Guidelines for the diagnosis and management of Clostridium diffi cile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997; 92: 739-50.
42. Vaezi MF, Richter JE. Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am J Gastroenterol 1999; 94: 3406-12.
43. Spechler SJ. American Gastroenterological Association medical position statement on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology 1999; 117: 229-33.
44. Cohen SH, Gerding DN, Johnson S et al. Clinical Practice Guidelines for Clostridium diffi cile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.
45. Moses RE, Feld AD. Legal risks of clinical practice guidelines. Am J Gastroenterol 2008; 103: 7-11.
46. Hyams AL, Brandenburg JA, Lipsitz SR et al. Practice guidelines and malpractice litigation: a two-way street. Ann Intern Med 1995; 122: 450-5.
47. Mendelson TB, Meltzer M, Campbell EG et al. Confl icts of interest in cardiovascular clinical practice guidelines. Arch Intern Med 2011; 171: 577-84.
48. ACC Signs on to Strict Code of Ethics; Cardiology Society reaffi rms its commitment to transparency and fi rewalls. [cited 6 September 2012]; available from: http://www.cardiosource.org/News-Media/Media-Center/News-Releases/2010/04/ Code-of-Ethics.aspx.
49. CMSS. Code for Interactions with Companies. [cited 6 September 2012]; available from: http://www.cmss.org/uploadedFiles/Site/CMSS-Policies/ CMSS%20Code%20for%20Interactions%20with%20Companies%20Appro ved%20Revised%20Version%203-19-11CLEAN.pdf.
50. GRADE working group. Grading the quality of evidence and the strength of recommendations. [cited 16 September 2012]; available from: http://www. gradeworkinggroup.org/intro.htm.
51. GRADE Online Learning Modules [cited 16 September 2012]; available from: http://cebgrade.mcmaster.ca/.